Literature DB >> 30706777

Exosome-like Nanoparticles: A New Type of Nanocarrier.

Mário Fernandes1,2, Ivo Lopes1,2, José Teixeira1, Cláudia Botelho1,2, Andreia C Gomes2.   

Abstract

Nanoparticles are one of the most commonly used systems for imaging or therapeutic drug delivery. Exosomes are nanovesicular carriers that transport cargo for intercellular communication. These nanovesicles are linked to the pathology of some major diseases, in some cases with a central role in their progression. The use of these carriers to transport therapeutic drugs is a recent and promising approach to treat diseases such as cancer and Alzheimer disease. The physiological production of these structures is limited impairing its collection and subsequent purification. These drawbacks inspired the search for mimetic alternatives. The collection of exosome-like nanoparticles from plants can be a good alternative, since they are easier to extract and do not have the drawbacks of those produced in animal cells. Both natural and synthetic exosome-like nanoparticles, produced from serial extrusion of cells or by bottom up synthesis, are currently some of the most promising, biocompatible, high efficiency systems for drug delivery. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Nanoparticles; drug delivery; exosome mimetics; exosome-like nanoparticles; exosomes; extracellular vesicles; nanomedicine.

Mesh:

Year:  2020        PMID: 30706777     DOI: 10.2174/0929867326666190129142604

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  9 in total

Review 1.  Non-viral vectors for RNA delivery.

Authors:  Yi Yan; Xiao-Yu Liu; An Lu; Xiang-Yu Wang; Lin-Xia Jiang; Jian-Cheng Wang
Journal:  J Control Release       Date:  2022-01-10       Impact factor: 9.776

Review 2.  Exosomes-mediated tumor treatment: One body plays multiple roles.

Authors:  Na Xu; Ranran Guo; Xiaotong Yang; Ning Li; Jia Yu; Peng Zhang
Journal:  Asian J Pharm Sci       Date:  2021-09-20       Impact factor: 9.273

Review 3.  Plasma-Enabled Smart Nanoexosome Platform as Emerging Immunopathogenesis for Clinical Viral Infection.

Authors:  Seyyed Mojtaba Mousavi; Seyyed Alireza Hashemi; Ahmad Gholami; Masoomeh Yari Kalashgrani; Neralla Vijayakameswara Rao; Navid Omidifar; Wesley Wei-Wen Hsiao; Chin Wei Lai; Wei-Hung Chiang
Journal:  Pharmaceutics       Date:  2022-05-13       Impact factor: 6.525

Review 4.  Nanomaterials for Inner Ear Diseases: Challenges, Limitations and Opportunities.

Authors:  Liling Li; Jia Luo; Xuexin Lin; Jingqian Tan; Peng Li
Journal:  Materials (Basel)       Date:  2022-05-25       Impact factor: 3.748

Review 5.  Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery.

Authors:  Tianjiao Geng; Patrick Pan; Euphemia Leung; Qi Chen; Larry Chamley; Zimei Wu
Journal:  Pharm Res       Date:  2021-02-18       Impact factor: 4.200

Review 6.  Red Blood Cell Extracellular Vesicle-Based Drug Delivery: Challenges and Opportunities.

Authors:  Wararat Chiangjong; Pukkavadee Netsirisawan; Suradej Hongeng; Somchai Chutipongtanate
Journal:  Front Med (Lausanne)       Date:  2021-12-24

Review 7.  Nanocarriers as Active Ingredients Enhancers in the Cosmetic Industry-The European and North America Regulation Challenges.

Authors:  Cristiana Oliveira; Cristina Coelho; José A Teixeira; Pedro Ferreira-Santos; Claudia M Botelho
Journal:  Molecules       Date:  2022-03-03       Impact factor: 4.411

8.  Characterization of Marine Organism Extracellular Matrix-Anchored Extracellular Vesicles and Their Biological Effect on the Alleviation of Pro-Inflammatory Cytokines.

Authors:  Sung-Han Jo; Seon-Hwa Kim; Changsu Kim; Sang-Hyug Park
Journal:  Mar Drugs       Date:  2021-10-21       Impact factor: 5.118

Review 9.  The Emerging Role of Plant-Derived Exosomes-Like Nanoparticles in Immune Regulation and Periodontitis Treatment.

Authors:  Zeyu Zhang; Yang Yu; Guanxiong Zhu; Liting Zeng; Shaofen Xu; Haoyu Cheng; Zhaoguang Ouyang; Jianwei Chen; Janak L Pathak; Lihong Wu; Lina Yu
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.